HHS to Provide $23 Mln to Merck for Ebola Vaccine Production HHS to Provide $23 Mln to Merck for Ebola Vaccine Production

The U.S. Department of Health and Human Services (HHS) said on Wednesday it will fund the manufacturing of Merck& Co Inc ' s investigational Ebola vaccine called V920, in response to the outbreak of the deadly virus in the Democratic Republic of the Congo (DRC).Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news